ClickCease

Continuous Glucose Monitors

Introducing the FreeStyle Libre


Say goodbye to daily fingerpricks. The FreeStyle Libre has made waves in the industry ever since it was launched. Now offering 14 day sensors. The battery life is great, up to 7 days use. The sensor is water resistant, however do not take it deeper than 3 feet if going swimming. Recently the FreeStyle Libre device has been approved by Medicare. It became so popular that orders on sensors were limited by customer.
Bedard Medical Supplies has a long history of helping patients manage their diabetes. We want to remain at the forefront of technology and what we offer to help you every step of the way. If the FreeStyle Libre does not work for you, we also carry CGM products from Dexcom and Medtronic.
If you would rather call us at 207-784-3700 we have experts ready to assist you! We also carry diabetic pumps, supplies and shoes. 
FreeStyle Libre continuous glucose monitoring

FreeStyle Libre

Now approved by Medicare, MaineCare, and most commercial insurance plans. Just fill out the short form above. Optional application on your phone called the LibreLink.

The Freestyle Libre CGM Reader
Up to 7 days of battery life
Rechargeable battery
3.74in x 2.36in x .63in
Just 2.3oz
90 day memory
The Freestyle Libre CGM Sensor
Up to 14 day life
Incredibly small at just .5cm height x 3.5cm tall
Weights only .18oz.
Water resistant

How does continuous glucose monitoring work?

Continuous glucose monitoring, or popularly known as CGM, is a way to track your glucose levels digitally. A small sensor is attached to your body which pulls your glucose levels and wirelessly transmits your glucose levels to your reader.

Where should I put my sensor?

My friend swears by having it on his upper arm, in-between his shoulder and tricep. Others stick it on their stomach, thigh, or lower back. I’ve heard of people who stick it on their calf. Most of the new sensors are just about pain free, so people have been experimenting more than when GCMs first came out.

Will it make my life easier?

Having diabetes is always going to be hard. It is the name of the game. Continuous glucose monitors really do make life much easier. We’ve seen people who have switched jobs just so they could get their GCMs covered by their insurance. Medicare is now making it easier than ever to get approvals. Why? Lancets and testers are not inexpensive either, and it really does provide a higher quality of life when used correctly. If your glucose levels are kept on a tighter leash, you’ll be healthier over the course of your life. Not to mention, less stressed!

Why choose Bedard Medical Supplies for my supply?

We’ve been helping people manage their diabetes longer than the oldest person in this world has lived. We’re a locally owned family company with local experts. We hire local people. We’ll fight for you when we have to. Just take a look at our online reviews. 

Does Medicare and MaineCare Cover Continuous Glucose Monitoring?

The short answer is yes. The long answer is, it depends. Our above online form is probably the easiest way to see if we think you could get yours approved. Below is the official wording.
A Continuous Glucose Monitoring system (CGM) is a U.S. Food and Drug Administration (FDA) approved device that records blood sugar levels throughout the day and night. There are several approved devices that can provide up to 288 blood sugar measurements every 24 hours. The system is used to measure an average blood sugar for three to seven days (depending on the model you have), while the person with diabetes continues daily activities at home.
1. Members 18 years of age or older and meets ALL of the following:
a. Diagnosis of diabetes (Type I & II); And
b. Using insulin analog injections at least 4 times daily or on insulin pump; And
c. Currently self-monitoring blood glucose at least 4 times daily documented for at least greater than or equal to eight (8) weeks; And
d. Worked with an endocrinologist or a mid-level provider working with an endocrinologist, And
e. Meets at least one of the following:
i. Failure of 3-7 day diagnostic Continuous Glucose Monitor use to reconcile hypoglycemia and subsequent treatment plan change (documented by scanned glucose meter downloads in the medical record); Or
ii. Two or more episodes of severe hypoglycemia per week (blood glucose <55 mg/dl) persisting despite therapy changes over at least the two months proceeding in the request; Or
iii. Severe hypoglycemic unawareness with blood glucose <55 mh/dl at least twice monthly over two months or once weekly in the last month (defined as documented Emergency Room (ER) visits, use of glucagon emergency kit, or loss of consciousness); Or
iv. Nocturnal hypoglycemia (blood glucose <55 mg/dl) refractory to insulin dose changes at least 2 times per week over the past two months; Or
v. Recurrent hypoglycemia seizures (1 or more hypoglycemia seizures in the past year); Or
vi. Patient with HgbA1c >7.5 and show compliance with plan of care as determined by endocrinologist to achieve tighter glucose control
Member is less than 18 years of age and meets ALL of the following:
a. Diagnosis of Type I diabetes; And
b. Provide clinical documentation indicating the member is using an insulin pump or multiple or multiple daily shot schedule – three or more shots daily or is a newly diagnosed diabetic member; And
c. Currently self-monitoring blood glucose testing at least 4 times daily
i. Documented for ≥8 weeks; Or
ii. Patient is ≤ 5 years old and newly diagnosed (within last 60 days)
d. Documented consistent visits with an endocrinologist
i. Every 3 months, over last 6-12 months and at least one (1) in-between phone contact with diabetes educator; Or
ii. Newly diagnosed (within last 60 days) and at least 4 visits and 2 calls documented in the last 8 weeks; Or
iii. Being discharged from hospital and endocrinologist documents need for immediate CGM
e. Ordered by an endocrinologist or a (mid-level provider (such as a physician assistant (PA) or nurse practitioner (NP)) working under the direct supervision of the endocrinologist; and
f. Meets at least one of the following:
i. Hypoglycemia unawareness-hypoglycemia requiring assistance from an adult and/or injection Glucagon or visit to ER at least twice within the last year; Or
ii. Under six (6) years of age or determined not competent to request assistance due to functional status specifically documented in medical records; Or
iii. Nocturnal hypoglycemia refractory to insulin dose changes at least 3 episodes documented in the last 3 months; Or
a. Hypoglycemia defined as <65 for children under 8 years of age
b. Defined as <55 for all others
iv. Seizure associated with Hypoglycemia – one or more episode in last 12 months; Or
v. Difficulty in accomplishing the target A1C, in a setting with a family and member in spite of working closely with endocrinologist and diabetes educator over the last 6 months. Must not be due to documented substantial non-compliance; Or
vi. Patient with HgbA1c >7.5 and highly motivated as determined by endocrinologist to achieve tighter glucose control.
3. ALL ages, Utilization Limits, replacement of the transmitter and/or receiver is allowed only when ALL of the following are met:
a. The member has successfully utilized long-term CGM as a supplement to self-monitoring of blood glucose, and benefitted from such monitoring (i.e. there is evidence the member has achieved improved glycemic control and/or experienced reduced incidences of hyperglycemia and hypoglycemia); And
b. Replacement with a comparable device is needed due to a malfunction; And
c. Since repair estimates are not possible for this equipment, documentation of malfunction is documented by clinical team; And
d. Must supply documentation that the member is using the CGM as directed by the endocrinologist or a mid-level provider (such as a physician assistant (PA) or nurse practitioner (NP)) working with an endocrinologist, And
e. Sensors approved for 6 months at a time. Sensors are supplied monthly for 6 months, And
f. A review of usage is required at month 5 prior to submitting by reauthorization at 6 months, And
g. Ongoing recommendation for CGM must be provided by an endocrinologist or a mid-level provider (such as a physician’s assistant (PA) or nurse practitioner (NP)) working with an endocrinologist